Decreased expression of kallikrein-related peptidase 13: Possible contribution to metastasis of human oral cancer

Molecular Carcinogenesis

Volumn 53, Issue 7, 2014, Pages 557-565

  Ishige, Shunsaku ^a   Kasamatsu, Atsushi ^a,b   Ogoshi, Kenji ^a   Saito, Yasuhiro ^a   Usukura, Katsuya ^a   Yokoe, Hidetaka ^c   Kouzu, Yukinao ^a   Koike, Hirofumi ^a   Sakamoto, Yosuke ^b   Ogawara, Katsunori ^a   Shiiba, Masashi ^a   Tanzawa, Hideki ^a,b   Uzawa, Katsuhiro ^a,b  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

^c NATIONAL DEFENSE MEDICAL COLLEGE HOSPITAL   (Japan)

Author keywords

Adhesion molecules; Invasiveness; Kallikrein related peptidase 13; Migration; Oral squamous cell carcinoma

Indexed keywords

ALPHA CATENIN; BETA CATENIN; DESMOCOLLIN; DESMOCOLLIN2; DESMOGLEIN 3; DESMOPLAKIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; KALLIKREIN 13; PLAKOGLOBIN; PLAKOPHILIN; PLAKOPHILIN4; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURGERY; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HSC 3 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; MOUTH SQUAMOUS CELL CARCINOMA; PRIMARY CELL LINE; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN DEPLETION; REGIONAL METASTASIS; SQUAMOUS CELL CARCINOMA CELL LINE; UPREGULATION;

ADHESION MOLECULES; INVASIVENESS; KALLIKREIN-RELATED PEPTIDASE 13; MIGRATION; ORAL SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; HUMANS; KALLIKREINS; LYMPHATIC METASTASIS; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR MARKERS, BIOLOGICAL;

EID: 84902548935     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22007     Document Type: Article

References (44)

1. Yousef GM, Diamandis EP. The new human tissue kallikrein gene family: Structure, function, and association to disease. Endocr Rev 2001; 22:184-204.
2. Yousef GM, Polymeris ME, Yacoub GM, et al. Parallel overexpression of seven kallikrein genes in ovarian cancer. Cancer Res 2003; 63:2223-2227.
3. Dong Y, Kaushal A, Brattsand M, Nicklin J, Clements JA. Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers. Clin Cancer Res 2003; 9:1710-1720.
4. Kountourakis P, Psyrri A, Scorilas A, et al. Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analyses (AQUA). Cancer Sci 2008; 99:2224-2229.
5. White NM, Mathews M, Yousef GM, Prizada A, Popadiuk C, Doré JJ. KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma. Br J Cancer 2009; 101:1107-1113.
6. Li X, Liu J, Wang Y, Zhang L, Ning L, Feng Y. Parallel underexpression of kallikrein 5 and kallikrein 7 mRNA in breast malignancies. Cancer Sci 2009; 100:601-607.
7. Yousef GM, Yacoub GM, Polymeris ME, Popalis C, Soosaipillai A, Diamandis EP. Kallikrein gene downregulation in breast cancer. Br J Cancer 2004; 90:167-172.
8. Yousef GM, Chang A, Diamandis EP. Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues. J Biol Chem 2000; 275:11891-11898.
9. Chang A, Yousef GM, Scorilas A, et al. Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: An independent indicator of favourable prognosis in breast cancer. Br J Cancer 2002; 86:1457-1464.
10. Stephan C, Jung K, Diamandis EP, Rittenhouse HG, Lein M, Loening SA. Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer. Urology 2002; 59:2-8.
11. Partin AW, Hanks GE, Klein EA, Moul JW, Nelson WG, Scher HI. Prostate-specific antigen as a marker of disease activity in prostate cancer. Oncology (Williston Park) 2002; 16:1218-1224; discussion 1224, 1227-1228 passim.
12. Rittenhouse HG, Finlay JA, Mikolajczyk SD, Partin AW. Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): Two closely related, but distinct, kallikreins in the prostate. Crit Rev Clin Lab Sci 1998; 35:275-368.
13. Stephan C, Jung K, Soosaipillai A, et al. Clinical utility of human glandular kallikrein 2 within a neural network for prostate cancer detection. BJU Int 2005; 96:521-527.
14. Yamano Y, Uzawa K, Shinozuka K, et al. Hyaluronan-mediated motility: A target in oral squamous cell carcinoma. Int J Oncol 2008; 32:1001-1009.
15. Kasamatsu A, Uzawa K, Nakashima D, et al. Galectin-9 as a regulator of cellular adhesion in human oral squamous cell carcinoma cell lines. Int J Mol Med 2005; 16:269-273.
16. Endo Y, Uzawa K, Mochida Y, et al. Sarcoendoplasmic reticulum Ca2+ ATPase type 2 downregulated in human oral squamous cell carcinoma. Int J Cancer 2004; 110:225-231.
17. Sakuma K, Kasamatsu A, Yamatoji M, et al. Expression status of Zic family member 2 as a prognostic marker for oral squamous cell carcinoma. J Cancer Res Clin Oncol 2010; 136:553-559.
18. Yamatoji M, Kasamatsu A, Yamano Y, et al. State of homeobox A10 expression as a putative prognostic marker for oral squamous cell carcinoma. Oncol Rep 2010; 23:61-67.
19. Lombardi DP, Geradts J, Foley JF, Chiao C, Lamb PW, Barrett JC. Loss of KAI1 expression in the progression of colorectal cancer. Cancer Res 1999; 59:5724-5731.
20. Kouzu Y, Uzawa K, Koike H, et al. Overexpression of stathmin in oral squamous-cell carcinoma: Correlation with tumour progression and poor prognosis. Br J Cancer 2006; 94:717-723.
21. Shimada K, Uzawa K, Kato M, et al. Aberrant expression of RAB1A in human tongue cancer. Br J Cancer 2005; 92:1915-1921.
22. Iyoda M, Kasamatsu A, Ishigami T, et al. Epithelial cell transforming sequence 2 in human oral cancer. PLoS ONE 2010; 5:e14082.
23. Verburg FA, Wäschle K, Reiners C, Giovanella L, Lentjes EG. Heterophile antibodies rarely influence the measurement of thyroglobulin and thyroglobulin antibodies in differentiated thyroid cancer patients. Horm Metab Res 2010; 42:736-739.
24. Petraki CD, Gregorakis AK, Papanastasiou PA, Karavana VN, Luo LY, Diamandis EP. Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissues. Prostate Cancer Prostatic Dis 2003; 6:223-227.
25. Konstantoudakis G, Florou D, Mavridis K, Papadopoulos IN, Scorilas A. Kallikrein-related peptidase 13 (KLK13) gene expressional status contributes significantly in the prognosis of primary gastric carcinomas. Clin Biochem 2010; 43:1205-1211.
26. Luo LY, Yousef GM, Diamandis EP. Human tissue kallikreins and testicular cancer. APMIS 2003; 111:225-232; discussion 232-233.
27. Jamora C, Fuchs E. Intercellular adhesion, signalling and the cytoskeleton. Nat Cell Biol 2002; 4:e101-e108.
28. Green KJ, Simpson CL. Desmosomes: New perspectives on a classic. J Invest Dermatol 2007; 127:2499-2515.
29. Dusek RL, Attardi LD. Desmosomes: New perpetrators in tumour suppression. Nat Rev Cancer 2011; 11:317-323.
30. South AP, Wan H, Stone MG, et al. Lack of plakophilin 1 increases keratinocyte migration and reduces desmosome stability. J Cell Sci 2003; 116:3303-3314.
31. Yin T, Green KJ. Regulation of desmosome assembly and adhesion. Semin Cell Dev Biol 2004; 15:665-677.
32. Wallis S, Lloyd S, Wise I, Ireland G, Fleming TP, Garrod D. The alpha isoform of protein kinase C is involved in signaling the response of desmosomes to wounding in cultured epithelial cells. Mol Biol Cell 2000; 11:1077-1092.
33. Krunic AL, Garrod DR, Smith NP, Orchard GS, Cvijetic OB. Differential expression of desmosomal glycoproteins in keratoacanthoma and squamous cell carcinoma of the skin: An immunohistochemical aid to diagnosis. Acta Derm Venereol 1996; 76:394-398.
34. Krunic AL, Garrod DR, Madani S, Buchanan MD, Clark RE. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: Actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin. Br J Cancer 1998; 77:1275-1279.
35. Kurzen H, Münzing I, Hartschuh W. Expression of desmosomal proteins in squamous cell carcinomas of the skin. J Cutan Pathol 2003; 30:621-630.
36. Yin T, Getsios S, Caldelari R, et al. Plakoglobin suppresses keratinocyte motility through both cell-cell adhesion-dependent and -independent mechanisms. Proc Natl Acad Sci USA 2005; 102:5420-5425.
37. Aktary Z, Pasdar M, Plakoglobin: Role in tumorigenesis and metastasis. Int J Cell Biol 2012; 2012:189521.
38. Chou RH, Lin SC, Wen HC, Wu CW, Chang WS. Epigenetic activation of human kallikrein 13 enhances malignancy of lung adenocarcinoma by promoting N-cadherin expression and laminin degradation. Biochem Biophys Res Commun 2011; 409:442-447.
39. Jiang R, Shi Z, Johnson JJ, Liu Y, Stack MS. Kallikrein-5 promotes cleavage of desmoglein-1 and loss of cell-cell cohesion in oral squamous cell carcinoma. J Biol Chem 2011; 286:9127-9135.
40. Ramsay AJ, Dong Y, Hunt ML, et al. Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progression. J Biol Chem 2008; 283:12293-12304.
41. Gratio V, Loriot C, Virca GD, et al. Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells. Am J Pathol 2011; 179:2625-2636.
42. Gratio V, Beaufort N, Seiz L, et al. Kallikrein-related peptidase 4: A new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells. Am J Pathol. 2010; 176:1452-1461.
43. Wang X, Liu HT, Li S, et al. Prognostic value of protease-activated receptor 2 expression in oesophageal squamous cell carcinoma. J Int Med Res 2010; 38:1381-1388.
44. Winter MC, Shasby SS, Ries DR, Shasby DM. PAR2 activation interrupts E-cadherin adhesion and compromises the airway epithelial barrier: Protective effect of beta-agonists. Am J Physiol Lung Cell Mol Physiol. 2006; 291:L628-L635.